ISAPS 2025: Key Takeaways from Dr. Choi's Presentation on 2,130 Breast Augmentation Cases

ISAPS 2025 World Congress: Singapore

At the prestigious International Society of Aesthetic Plastic Surgery (ISAPS) 2025 World Congress held in Singapore, Dr. Sangmun Choi presented groundbreaking research that has significant implications for the field of breast augmentation surgery.

The Study: Six Years of Data

Dr. Choi's presentation covered a comprehensive retrospective analysis spanning six years (2019-2025), examining outcomes from 2,130 breast augmentation surgeries performed using Motiva Ergonomic Implants with the Preservé tissue-preserving technique.

Study Parameters

Total Cases: 2,130 patients

Study Period: 2019-2025

Implant Type: Motiva Ergonomic with SmoothSilk® Nano-Surface

Surgical Technique: Preservé (tissue-preserving approach)

Follow-up: Minimum 12 months post-operative

Key Findings

Safety Profile

The most striking finding was the exceptional safety profile:

Zero cases of BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma)

Capsular contracture rate: Less than 1% (Baker Grade III-IV)

Seroma incidence: Minimal, well below industry averages

Reoperation rate: Significantly lower than published norms

Patient Satisfaction

95.2% of patients reported high satisfaction with aesthetic outcomes

97.8% would recommend the procedure to others

Average recovery time to normal activities: 2.3 days

Complication Rates Compared to Industry Standards

| Complication | Study Rate | Industry Average |

|---|---|---|

| Capsular Contracture (III-IV) | <1% | 8-15% |

| Reoperation | 2.1% | 8-12% |

| Infection | 0.3% | 1-2% |

| Seroma | 0.5% | 2-4% |

Significance of the Research

This study represents one of the largest single-surgeon series using the Preservé technique with Motiva implants. The results demonstrate that combining tissue-preserving surgical techniques with advanced implant technology can significantly reduce complication rates while improving patient outcomes.

Implications for Clinical Practice

Dr. Choi's research supports several important clinical conclusions:

Tissue preservation matters: Minimizing surgical trauma directly correlates with better outcomes

Surface technology is critical: SmoothSilk® Nano-Surface shows superior biocompatibility

Ergonomic design advantages: Natural movement and shape adaptation improve long-term satisfaction

Standardized technique improves consistency: A systematic approach yields reproducible results

Global Recognition

The presentation received significant attention from the international plastic surgery community, with multiple surgeons expressing interest in adopting the Preservé approach. Dr. Choi was recognized as a Motiva Global KOL (Key Opinion Leader) for the second consecutive year.

Looking Forward

This research opens new avenues for further study, including longer-term follow-up data and comparative studies with other surgical techniques. Dr. Choi continues to refine the Preservé approach and share his findings with the global surgical community.

This article summarizes the key findings presented at ISAPS 2025. For the full research paper, please contact Ryan Plastic Surgery.